GGrantIndex
← Leaderboards

Mathew L Thakur

Palatin Technologies, Inc.

Google Scholar ↗PubMed ↗ORCID ↗
$8,967,199
Attributed
$12,632,706
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2005–24
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$12,632,706 · 11

By mechanism

R01$9,831,092 · 5
S10$975,338 · 3
R44$834,494 · 1
R42$711,631 · 1
P30$280,151 · 1

Top collaborators

Others in their field

Top investigators on “Image”

Research focus

ImagePositron-Emission TomographyMalignant - DescriptorBenignCellsMalignant NeoplasmsBiopsyInvestigationDiagnosisPeptidesProceduresLifeCancer CellReceptorOverexpressionBloodMalignant Neoplasm Of ProstateEffectivenessCancer PatientLabelMalignant Breast NeoplasmMolecular ImagingMorbidity - Disease RateDesign

Grant awards (31)

Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer$564,183
R01 · FY2024 · CA · contact PI
Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer$582,001
R01 · FY2023 · CA · contact PI
Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer$582,001
R01 · FY2022 · CA · contact PI
Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer$593,229
R01 · FY2021 · CA · contact PI
Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer$700,603
R01 · FY2020 · CA · contact PI
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer$380,300
R01 · FY2017 · CA · contact PI
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer$490,625
R01 · FY2016 · CA · contact PI
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer$528,829
R01 · FY2015 · CA · contact PI
SPECT/CT for Molecular Imaging Facility at TJU$300,383
S10 · FY2014 · OD · contact PI
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer$136,839
R01 · FY2014 · CA · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$519,862
R01 · FY2013 · CA
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer$494,661
R01 · FY2013 · CA · contact PI
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer$574,298
R01 · FY2012 · CA · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$563,160
R01 · FY2012 · CA
Small Animal Imaging$90,024
P30 · FY2012 · CA · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$586,293
R01 · FY2011 · CA
Small Animal Imaging$92,316
P30 · FY2011 · CA · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$623,627
R01 · FY2010 · CA
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer$376,588
R44 · FY2010 · CA
Optical imaging for Translational Cancer Research$174,955
S10 · FY2010 · RR · contact PI
Small Animal Imaging$97,811
P30 · FY2010 · CA · contact PI
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer$342,141
R44 · FY2009 · CA
PET for Molecular Imaging of Small Animals$500,000
S10 · FY2008 · RR · contact PI
PET Imaging of Breast Cancer Using Oncogene Expression$404,031
R01 · FY2008 · CA · contact PI
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer$115,765
R44 · FY2008 · CA
PET Imaging of Breast Cancer Using Oncogene Expression$433,780
R01 · FY2007 · CA · contact PI
PET Imaging of Breast Cancer Using Oncogene Expression$410,453
R01 · FY2006 · CA · contact PI
Improved Molecular Imaging with SPECT$340,555
R01 · FY2006 · EB · contact PI
PET Imaging of Breast Cancer Using Oncogene Expression$321,762
R01 · FY2005 · CA
IMAGING THROMBOEMBOLISM WITH FIBRIN AVID TC-99M-PEPTIDE$374,330
R42 · FY2002 · HL
IMAGING THROMBOEMBOLISM WITH FIBRIN AVID TC-99M-PEPTIDE$337,301
R42 · FY2001 · HL